Mersana Therapeutics, Inc. (MRSN): Price and Financial Metrics
MRSN Price/Volume Stats
| Current price | $2.22 | 52-week high | $6.28 |
| Prev. close | $2.22 | 52-week low | $1.22 |
| Day low | $2.15 | Volume | 671,900 |
| Day high | $2.35 | Avg. volume | 1,607,272 |
| 50-day MA | $2.07 | Dividend yield | N/A |
| 200-day MA | $2.70 | Market Cap | 274.24M |
MRSN Stock Price Chart Interactive Chart >
Mersana Therapeutics, Inc. (MRSN) Company Bio
Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
MRSN Price Returns
| 1-mo | 8.29% |
| 3-mo | 42.31% |
| 6-mo | -6.72% |
| 1-year | 48.49% |
| 3-year | -70.79% |
| 5-year | -31.27% |
| YTD | -4.31% |
| 2023 | -60.41% |
| 2022 | -5.79% |
| 2021 | -76.63% |
| 2020 | 364.40% |
| 2019 | 40.44% |
Continue Researching MRSN
Want to do more research on Mersana Therapeutics Inc's stock and its price? Try the links below:Mersana Therapeutics Inc (MRSN) Stock Price | Nasdaq
Mersana Therapeutics Inc (MRSN) Stock Quote, History and News - Yahoo Finance
Mersana Therapeutics Inc (MRSN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...